Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hereceptin Biosimilars Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hereceptin Biosimilars Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Capsule
      • 1.3.3 Tablet
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hereceptin Biosimilars Market Share by Application (2019-2025)
      • 1.4.2 Healthcare & Pharmaceuticals
      • 1.4.3 Personal Care
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hereceptin Biosimilars Market Size
      • 2.1.1 Global Hereceptin Biosimilars Revenue 2014-2025
      • 2.1.2 Global Hereceptin Biosimilars Sales 2014-2025
    • 2.2 Hereceptin Biosimilars Growth Rate by Regions
      • 2.2.1 Global Hereceptin Biosimilars Sales by Regions 2014-2019
      • 2.2.2 Global Hereceptin Biosimilars Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hereceptin Biosimilars Sales by Manufacturers
      • 3.1.1 Hereceptin Biosimilars Sales by Manufacturers 2014-2019
      • 3.1.2 Hereceptin Biosimilars Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hereceptin Biosimilars Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hereceptin Biosimilars Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hereceptin Biosimilars Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hereceptin Biosimilars Price by Manufacturers
    • 3.4 Key Manufacturers Hereceptin Biosimilars Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hereceptin Biosimilars Market
    • 3.6 Key Manufacturers Hereceptin Biosimilars Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Capsule Sales and Revenue (2014-2019)
      • 4.1.2 Tablet Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Hereceptin Biosimilars Sales Market Share by Type
    • 4.3 Global Hereceptin Biosimilars Revenue Market Share by Type
    • 4.4 Hereceptin Biosimilars Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hereceptin Biosimilars Sales by Application

    6 United States

    • 6.1 United States Hereceptin Biosimilars Breakdown Data by Company
    • 6.2 United States Hereceptin Biosimilars Breakdown Data by Type
    • 6.3 United States Hereceptin Biosimilars Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hereceptin Biosimilars Breakdown Data by Company
    • 7.2 European Union Hereceptin Biosimilars Breakdown Data by Type
    • 7.3 European Union Hereceptin Biosimilars Breakdown Data by Application

    8 China

    • 8.1 China Hereceptin Biosimilars Breakdown Data by Company
    • 8.2 China Hereceptin Biosimilars Breakdown Data by Type
    • 8.3 China Hereceptin Biosimilars Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hereceptin Biosimilars Breakdown Data by Company
    • 9.2 Rest of World Hereceptin Biosimilars Breakdown Data by Type
    • 9.3 Rest of World Hereceptin Biosimilars Breakdown Data by Application
    • 9.4 Rest of World Hereceptin Biosimilars Breakdown Data by Countries
      • 9.4.1 Rest of World Hereceptin Biosimilars Sales by Countries
      • 9.4.2 Rest of World Hereceptin Biosimilars Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Mylan N.V
      • 10.1.1 Mylan N.V Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.1.4 Hereceptin Biosimilars Product Introduction
      • 10.1.5 Mylan N.V Recent Development
    • 10.2 Amgen Inc.
      • 10.2.1 Amgen Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.2.4 Hereceptin Biosimilars Product Introduction
      • 10.2.5 Amgen Inc. Recent Development
    • 10.3 Mabion S.A.
      • 10.3.1 Mabion S.A. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.3.4 Hereceptin Biosimilars Product Introduction
      • 10.3.5 Mabion S.A. Recent Development
    • 10.4 AryoGen Biopharma
      • 10.4.1 AryoGen Biopharma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.4.4 Hereceptin Biosimilars Product Introduction
      • 10.4.5 AryoGen Biopharma Recent Development
    • 10.5 Genor Biopharma
      • 10.5.1 Genor Biopharma Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.5.4 Hereceptin Biosimilars Product Introduction
      • 10.5.5 Genor Biopharma Recent Development
    • 10.6 Celltrion Inc.
      • 10.6.1 Celltrion Inc. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.6.4 Hereceptin Biosimilars Product Introduction
      • 10.6.5 Celltrion Inc. Recent Development
    • 10.7 Gedeon Richter
      • 10.7.1 Gedeon Richter Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.7.4 Hereceptin Biosimilars Product Introduction
      • 10.7.5 Gedeon Richter Recent Development
    • 10.8 The Instituto Vital Brazil
      • 10.8.1 The Instituto Vital Brazil Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.8.4 Hereceptin Biosimilars Product Introduction
      • 10.8.5 The Instituto Vital Brazil Recent Development
    • 10.9 F. Hoffmann-La Roche AG
      • 10.9.1 F. Hoffmann-La Roche AG Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.9.4 Hereceptin Biosimilars Product Introduction
      • 10.9.5 F. Hoffmann-La Roche AG Recent Development
    • 10.10 Biocons
      • 10.10.1 Biocons Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Hereceptin Biosimilars
      • 10.10.4 Hereceptin Biosimilars Product Introduction
      • 10.10.5 Biocons Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hereceptin Biosimilars Sales Channels
      • 11.2.2 Hereceptin Biosimilars Distributors
    • 11.3 Hereceptin Biosimilars Customers

    12 Market Forecast

    • 12.1 Global Hereceptin Biosimilars Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hereceptin Biosimilars Sales Forecast by Type
    • 12.3 Global Hereceptin Biosimilars Sales Forecast by Application
    • 12.4 Hereceptin Biosimilars Forecast by Regions
      • 12.4.1 Global Hereceptin Biosimilars Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hereceptin Biosimilars Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in the body. Herceptin biosimilars are essentially used to treat certain breast as well stomach cancers, and is also used in combination with other medicines for treatment.
      In 2019, the market size of Hereceptin Biosimilars is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hereceptin Biosimilars.

      This report studies the global market size of Hereceptin Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hereceptin Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Mylan N.V
      Amgen Inc.
      Mabion S.A.
      AryoGen Biopharma
      Genor Biopharma
      Celltrion Inc.
      Gedeon Richter
      The Instituto Vital Brazil
      F. Hoffmann-La Roche AG
      Biocons

      Market Segment by Product Type
      Capsule
      Tablet
      Others

      Market Segment by Application
      Healthcare & Pharmaceuticals
      Personal Care
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hereceptin Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hereceptin Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hereceptin Biosimilars are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now